These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14588214)

  • 1. [FMRP immunodetection on hair roots: application to the diagnosis of fragile X syndrome].
    Rifé Soler M; Sánchez Díaz A; Ramos F; Milà Recasens M
    An Pediatr (Barc); 2003 Nov; 59(5):431-5. PubMed ID: 14588214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
    Ramos-Fuentes FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive test for fragile X syndrome, using hair root analysis.
    Willemsen R; Anar B; De Diego Otero Y; de Vries BB; Hilhorst-Hofstee Y; Smits A; van Looveren E; Willems PJ; Galjaard H; Oostra BA
    Am J Hum Genet; 1999 Jul; 65(1):98-103. PubMed ID: 10364521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the fragile X syndrome among mentally retarded males by hair root analysis.
    Tunçbilek E; Alikasifoğlu M; Aktas D; Duman F; Yanik H; Anar B; Oostra B; Willemsen R
    Am J Med Genet; 2000 Nov; 95(2):105-7. PubMed ID: 11078558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome].
    Luo XF; Zhong JM; Zhang XZ; Zou Y; Chen Y; Wu HP; Yu XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):817-20. PubMed ID: 19849940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening with the FMR1 protein test among mentally retarded males.
    de Vries BB; Mohkamsing S; van den Ouweland AM; Halley DJ; Niermeijer MF; Oostra BA; Willemsen R
    Hum Genet; 1998 Oct; 103(4):520-2. PubMed ID: 9856500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene.
    Govaerts LC; Smit AE; Saris JJ; VanderWerf F; Willemsen R; Bakker CE; De Zeeuw CI; Oostra BA
    Clin Genet; 2007 Aug; 72(2):138-44. PubMed ID: 17661818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome.
    Lessard M; Chouiali A; Drouin R; Sébire G; Corbin F
    Clin Genet; 2012 Nov; 82(5):472-7. PubMed ID: 21992468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
    Salat U; Bardoni B; Wöhrle D; Steinbach P
    J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay.
    LaFauci G; Adayev T; Kascsak R; Kascsak R; Nolin S; Mehta P; Brown WT; Dobkin C
    J Mol Diagn; 2013 Jul; 15(4):508-17. PubMed ID: 23660422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
    Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique.
    Willemsen R; Smits A; Mohkamsing S; van Beerendonk H; de Haan A; de Vries B; van den Ouweland A; Sistermans E; Galjaard H; Oostra BA
    Hum Genet; 1997 Mar; 99(3):308-11. PubMed ID: 9050914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fragile X syndrome.
    de Vries BB; Halley DJ; Oostra BA; Niermeijer MF
    J Med Genet; 1998 Jul; 35(7):579-89. PubMed ID: 9678703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C; Nielsen AL
    Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X syndrome (review).
    Pimentel MM
    Int J Mol Med; 1999 Jun; 3(6):639-45. PubMed ID: 10341296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.